Neurogene Inc. (NGNE)
USD 21.79
(-8.14%)
USD 21.79
(-8.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -51.42 Million | -52.82 Million | -46.4 Million | -24.57 Million | -15.39 Million | -31.57 Million |
| Net Income | -36.31 Million | -55.18 Million | -50.51 Million | -33.27 Million | -69.44 Million | -31.58 Million |
| Depreciation & Amortization | 3.29 Million | 3.2 Million | 947 Thousand | 1.82 Million | 340 Thousand | - |
| Deferred income taxes | -105 Thousand | - | - | - | - | - |
| Stock-based compensation | 1.41 Million | 1.25 Million | 896 Thousand | - | - | - |
| Change in working capital | -4.02 Million | -2.69 Million | 1.59 Million | 966 Thousand | -1.95 Million | -5.43 Million |
| Other non-cash items | -15.69 Million | 608 Thousand | 679 Thousand | 9.55 Million | 56.05 Million | 5.43 Million |
| Investing Cash Flow | 25.63 Million | -2.23 Million | -18.36 Million | -2.21 Million | -688 Thousand | 55.95 Million |
| Investments in PPE | -321 Thousand | -2.23 Million | -18.36 Million | -2.21 Million | -879 Thousand | -49 Thousand |
| Acquisitions | 20.95 Thousand | - | - | - | 191 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 5 Million | - | - | - | - | 56 Million |
| Other Investing Activities | 20.95 Million | - | - | - | - | - |
| Financing Cash Flow | 92.48 Million | 66.53 Million | 51.06 Million | 77.13 Million | 82.23 Million | 570 Thousand |
| Debt repayment | -29 Thousand | -1000.00 | -51 Thousand | -49 Thousand | -9000.00 | -32 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 92.34 Million | 66.53 Million | 783 Thousand | 77.18 Million | 82.24 Million | 602 Thousand |
| Other Financing Activities | 92.34 Million | 66.53 Thousand | 51.06 Thousand | - | - | - |
| Accounts receivables | - | - | - | - | 290 Thousand | - |
| Accounts payables | 667 Thousand | -3.6 Million | 2.98 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -4.69 Million | 912 Thousand | -1.38 Million | 966 Thousand | -2.24 Million | -5.43 Million |
| Cash at beginning of period | 82.02 Million | 70.54 Million | 84.25 Million | 143.09 Million | 76.92 Million | 52.03 Million |
| Cash at end of period | 148.71 Million | 82.02 Million | 70.54 Million | 192.55 Million | 143.09 Million | 76.92 Million |
| Capital Expenditure | -321 Thousand | -2.23 Million | -18.36 Million | -2.21 Million | -879 Thousand | -49 Thousand |
| Effect of forex changes on cash | - | - | - | -878 Thousand | 10 Thousand | - |
| Net cash flow / Change in cash | 66.69 Million | 11.47 Million | -13.7 Million | 49.46 Million | 66.16 Million | 24.89 Million |
| Free Cash Flow | -51.74 Million | -55.05 Million | -64.76 Million | -26.79 Million | -16.27 Million | -31.62 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -18.49 Million | -16.92 Million | -15.5 Million | -36.31 Million | -4.52 Million | -2.08 Million |
| Depreciation & Amortization | 817 Thousand | 825 Thousand | 1.89 Million | 3.29 Million | 381 Thousand | 371 Thousand |
| Deferred income taxes | - | - | - | -105 Thousand | - | - |
| Stock-based compensation | 2.31 Million | 1.04 Million | 355.00 | 1.41 Million | 386.00 | 384 Thousand |
| Change in working capital | -825.01 Thousand | -6.74 Million | 1.26 Million | -4.02 Million | 257.4 Thousand | -1.8 Million |
| Other non-cash items | 4.27 Million | 2.71 Million | -13.38 Million | -15.69 Million | 351.18 Thousand | 148.04 Thousand |
| Investing Cash Flow | -23.65 Million | 29.93 Million | 16.68 Million | 25.63 Million | -1.61 Million | -374.61 Thousand |
| Investments in PPE | -456.28 Thousand | -65 Thousand | 235.22 Thousand | -321 Thousand | -369.54 | -133.94 Thousand |
| Acquisitions | - | - | -2.12 Million | 20.95 Thousand | 1418.48 | 2.12 Million |
| Investment purchases | -42.35 Million | - | 92.26 Million | - | -36.8 Million | -27.08 Million |
| Sales/Maturities of investments | 19.14 Million | 30 Million | -94.46 Million | 5 Million | 35.19 Million | 24.72 Million |
| Other Investing Activities | -23.15 Million | 30 Thousand | 20.76 Million | 20.95 Million | 1.06 | - |
| Financing Cash Flow | 442.34 Thousand | -6.52 Million | 92 Million | 92.48 Million | -1245.65 | -295.27 Thousand |
| Debt repayment | -15.8 Thousand | -11 Thousand | -337.79 Thousand | -29 Thousand | -1248.33 | -299.28 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 407.61 Thousand | 629 Thousand | 162.46 Thousand | 92.34 Million | 2.68 | 4014.14 |
| Other Financing Activities | 50.54 Thousand | -7.14 Million | 91.5 Million | 92.34 Million | -1826.00 | 10.50 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 230.39 Thousand | 135 Thousand | - | 667 Thousand | - | 27 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.05 Million | -6.88 Million | 608.45 Thousand | -4.69 Million | 257.4 Thousand | -1.8 Million |
| Cash at beginning of period | 150.14 Million | 148.21 Million | 25.22 Million | 82.02 Million | 31.11 Million | 35.49 Million |
| Cash at end of period | 111.03 Million | 150.14 Million | 148.21 Million | 148.71 Million | 25.22 Million | 31.11 Million |
| Capital Expenditure | -456.28 Thousand | -65 Thousand | 235.22 Thousand | -321 Thousand | -369.54 | -133.94 Thousand |
| Effect of forex changes on cash | - | - | 43.8 Million | - | 29.53 Thousand | 395.26 Thousand |
| Net cash flow / Change in cash | -39.1 Million | 1.93 Million | 122.98 Million | 66.69 Million | -5.88 Million | -4.38 Million |
| Free Cash Flow | -16.08 Million | -21.71 Million | -29.28 Million | -51.74 Million | -4.29 Million | -4.24 Million |
PCLOF
8620
CBSTF
BTURF
SBOK
GLOBALVECT